How Analytics from Infosys Life Science Insights Platform Improves Patient Outcomes
As COVID-19 continues to evolve at unprecedented speed and scale, the life sciences industry is at the epicenter of developing tests and treatments and getting them to the masses. Drug researchers around the world are scrambling to develop vaccines and other treatments in an attempt to slow the spread of the disease.
Thanks to artificial intelligence (AI) capabilities to crunch massive amounts of data in a short period of time, drug development pipelines that would normally take over a decade are being compressed into a matter of months.
Infosys Data & Analytics Practice and Amazon Web Services (AWS) have collaborated to develop the Infosys Life Science Commercial Insights Platform that addresses such needs.
Read the full blog on AWS portal.